XML 30 R13.htm IDEA: XBRL DOCUMENT
v3.21.2

Nonconsolidated Entities | 12 Months Ended
--- | ---
Jun. 30, 2021
Nonconsolidated Entities |
Nonconsolidated Entities | Note 6:Nonconsolidated Entities Prior to January 1, 2021, the Company had two nonconsolidated equity method investments; PWD and InnovAge Sacramento. On March 18, 2019, in connection with the formation of InnovAge Sacramento, the joint venture with Adventist Health System/West (“Adventist”) and Eskaton Properties, Incorporated (“Eskaton”), the Company contributed $9.0 million in cash and land valued at $4.2 million for a 59.9% membership interest in the joint venture, InnovAge Sacramento. Further, Adventist contributed $5.8 million in cash and Eskaton contributed $3.0 million in cash for membership interests of 26.41% and 13.69%, respectively. The Company made an additional contribution of $52,000 to obtain an additional 0.1% membership interest in the joint venture. With the acquisition of the additional 0.1% membership interest, the Company obtained control of InnovAge Sacramento effective January 1, 2021. Accordingly, beginning January 1, 2021, the results of InnovAge Sacramento are included in our consolidated results of operations. The InnovAge California PACE-Sacramento LLC Limited Liability Company Agreement (the “JV Agreement”) includes numerous provisions whereby, if certain conditions are met, the joint venture may be required to purchase, at fair market value, certain members’ interests or certain members’ may be required to purchase, at fair market value, the interests of certain other members. As of June 30, 2021, none of the conditions specified in the JV Agreement had been met. At the consummation of the JV Agreement, the Company issued to Adventist, warrants (the “Sacramento Warrants”) to purchase 5% of the Company’s issued and outstanding common stock, par value $0.001 at an exercise price equal to the fair market value per share at the time of exercise of this warrant. The Sacramento Warrants fully vest on the exercise date, which is defined as the date on which Adventist has made aggregate capital contributions in an amount greater than $25.0 million to one or more joint venture entities in which Adventist and the Company hold equity (the “Investment Threshold”). On February 9, 2021, the Company entered into an amendment agreement with our joint venture partner Adventist to amend the Sacramento Warrants. The amendment removes the Investment Threshold requirement and grants Adventist the right to purchase up to $15.0 million of the Company’s common stock at an exercise price equal to the IPO price. The warrant is exercisable for one year beginning on the date of the consummation of the IPO. As of June 30, 2021, Adventist had not exercised any warrants. At inception, the Sacramento Warrants were initially determined to be equity-based payments to nonemployees and as such the measurement date for these warrants was considered to be the date when the Investment Threshold is reached. At the time of the amendment, due to the removal of the Investment Threshold, the warrants were evaluated under ASC 815-40, Contracts in an Entity’s Own Equity, which resulted in a liability classification from the date of the amendment through completion of our IPO, due to the variable amount of shares which could be issued. Upon completion of the IPO, the number of shares to be issued were no longer variable, which resulted in the warrants being recorded in equity. In 2021, we recorded a charge of $2.3 million, representing the fair value of the warrants from inception through the date of completion of the IPO, in other income (expense) in the condensed consolidated statement of operations. Effective January 1, 2021, we obtained control of InnovAge Sacramento through acquisition of an additional 0.1% membership interest, which we consider to be a step acquisition, whereby the Company re-measured the previously held equity method investment to fair value. This resulted in a gain on consolidation of $10.9 million, which is recorded in gain on equity method investment in the condensed consolidated statement of operations. The fair value of the previously held equity investments was determined using a discounted cash flow model. We accounted for the transaction as a business combination, which requires that we record the assets acquired and liabilities assumed at fair value. The amount by which the purchase price exceeds the fair value of the net assets acquired is recorded as goodwill. The fair value of the assets acquired and net liabilities assumed in the step acquisition are as follows as of January 1, 2021: ​
​ | ​ | ​ | ​
​ |  | January 1,
​ |  | 2021
Assets: | ​ | in thousands
Cash | ​ | $ | 646
Accounts receivable | ​ | ​ | 786
Property and equipment, net | ​ | ​ | 30,667
Goodwill | ​ | ​ | 8,078
Total assets | ​ |  | 40,177
​ | ​ | ​ | ​
Liabilities: | ​ |  |
Accounts payable | ​ |  | 530
Reported and estimated claims | ​ | ​ | 330
Due to Medicaid and Medicare | ​ | ​ | 77
Capital leases | ​ | ​ | 428
Other liabilities | ​ |  | 48
Total liabilities | ​ | $ | 1,413
​ The following table sets forth the results of InnovAge Sacramento for the six months ended December 31, 2020. The results of InnovAge Sacramento are consolidated beginning January 1, 2021. ​
​ | ​ | ​ | ​
​ |  | Six Months Ended
​ | ​ | December 31, 2020
​ |  | in thousands
Revenue: | ​ | ​ | ​
Total revenue | ​ | $ | 2,297
Less: members’ interest | ​ |  | 921
The Company’s interest | ​ |  | 1,376
Cost of operations: | ​ |  |
Total cost of operations | ​ |  | 4,538
Less: members’ interest | ​ |  | 1,820
The Company’s interest | ​ |  | 2,718
The Company’s interest in net loss | ​ | $ | (1,342)
​

X
- References No definition available. + Details
Name: | innv_NonconsolidatedEntitiesAbstract
Namespace Prefix: | innv_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for nonconsolidated entities. + References No definition available. + Details
Name: | innv_NonconsolidatedEntitiesTextBlock
Namespace Prefix: | innv_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration